跳至主要内容
临床试验/IRCT20090822002365N30
IRCT20090822002365N30尚未招募3 期

The effect of magnesium and omega 3 co-supplementation on muscle strength, physical performance, muscle mass, inflammation, and intrinsic capacity index in elderly with sarcopenia: A double-blind randomized placebo-control trial

Iran University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 84 years(—)
性别
All

入选标准

  • Complete and sign informed consent
  • Age 60-84 years
  • Diagnosis of possible sarcopenia according to update of Asian Working Group for Sarcopenia (AWGS) (hand grip strength less than 28 kg in men and less than 18 kg in women)
  • Impaired intrinsic capacity according to the first step of ICOPE guidelines of the World Health Organization
  • Required no or some support with self-care (feeding, bathing, dressing, toileting).
  • Taking any supplements containing magnesium and omega-3 during the last 2 months
  • Taking any supplements containing more than 100 mg magnesium

排除标准

  • Acute cardiovascular diseases, acute infection, and acute cerebrovascular disease
  • Severe cardiac, liver, kidney dysfunction, autoimmune
  • Uncontrolled diabetes
  • Dementia, Parkinsons disease, and mental illnesses
  • unable to provide informed consent because of aphasia, deafness, and blindness
  • Physically-handicapped, disability, and use of a wheelchair or walker
  • Taking hormonal drugs
  • Acute illness (cold, corona and any other viral-bacterial-fungal disease)
  • Taking steroidal and non-steroidal anti-inflammatory drugs, aminoglycoside antibiotics, laxatives and laxatives

研究者

相似试验